Option Care Health Inc (OPCH) valuation
Option Care Health P/E ratio history
Option Care Health trades at 24.1 times its earnings over the last twelve months and 16.1 times the earnings analysts expect over the next twelve. At its last 5 fiscal year ends its P/E ranged from 18.9 (year to Dec 2024) to 36.9 (year to Dec 2021), with a median of 25.1.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $31.86 | $1.27 | 25.1 | 17.3 |
| Dec 31, 2024 | $23.20 | $1.23 | 18.9 | 17.7 |
| Dec 31, 2023 | $33.69 | $1.48 | 22.8 | — |
| Dec 31, 2022 | $30.09 | $0.83 | 36.3 | 32.4 |
| Dec 31, 2021 | $28.44 | $0.77 | 36.9 | 35.8 |
| Dec 31, 2020 | $15.64 | -$0.04 | n/m | — |
| Dec 31, 2019 | $14.92 | -$0.48 | n/m | — |
| Dec 31, 2018 | $14.28 | — | n/m | — |
| Dec 31, 2017 | $11.64 | — | n/m | — |
| Dec 31, 2016 | $4.16 | -$2.24 | n/m | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Option Care Health valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Option Care HealthOPCH | $5.00B | 24.1 | 16.1 | 0.9 |
| Ptc TherapeuticsPTCT | $5.00B | — | 27.8 | 4.3 |
| Crispr Therapeutics AgCRSP | $4.96B | — | — | 370.3 |
| HeartflowHTFL | $5.09B | 19.4 | — | 24.0 |
| Merit Medical SystemsMMSI | $5.15B | 32.3 | 18.9 | 3.2 |
| Concentra Group Holdings Parent InCON | $5.17B | 26.1 | 23.1 | 2.3 |
| Mirum PharmaceuticalsMIRM | $5.18B | — | — | 8.4 |
| Lifestance Health GroupLFST | $5.20B | 103.3 | 33.9 | 3.3 |
| Scholar Rock HoldingSRRK | $5.26B | — | — | — |
| Peer median | 29.2 | 25.4 | 4.3 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: OPCH financials · OPCH returns
No forecast, no recommendation. This page describes Option Care Health Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.